Related content

Phase II study of oxaliplatin, UFT, and leucovorin in patients with metastatic gastric cancer

By Siemerink Ester   Drenth Annemieke   Mulder Nanno   Plukker John   Hospers Geke  

Gastric Cancer, Vol. 13, Iss. 2, 2010-06 ,pp. : 95-100

Springer Publishing Company

Access to resources Recommend Favorite

A phase II study of UFT and leucovorin in combination with mitomycin C in patients with metastatic colorectal cancer

By Gyldenkerne Niels   Glimelius Bengt   Frödin Jan Erik   Kjaer Mogens   Pfeiffer Per   Hansen Flemming   Keldsen Nina   Sandberg Erik   Jakobsen Anders  

Acta Oncologica, Vol. 43, Iss. 3, 2004-04 ,pp. : 276-279

Informa Healthcare

Access to resources Recommend Favorite

Phase II trial of gemcitabine and S-1 for patients with advanced pancreatic cancer

By Song Hunho   Han Boram   Park Choong   Kim Jong   Jeon Jang   Kim In-Gyu   Kim Hyo   Jung Joo   Kim Jung   Kwon Jung   Jang Geundoo   Kim Ho   Kim Hyeong   Choi Dae   Zang Dae  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 4, 2013-10 ,pp. : 845-852

Springer Publishing Company

Access to resources Recommend Favorite

Phase II Study of Pemetrexed Plus Gemcitabine in Advanced Pancreatic Cancer

By Kindler Hedy L.  

American Journal of Cancer, Vol. 4, Iss. 3, 2005-01 ,pp. : 185-191

Adis International

Access to resources Recommend Favorite

A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer

By Song Hong   Do Young   Chang Heung   Ryu Min   Lee Kyung   Kim Yeul   Hong Dae   Cho Jae   Lee Kyoung   Kim Si  

Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 5, 2008-10 ,pp. : 763-768

Springer Publishing Company

Access to resources Recommend Favorite